Details for Patent: 8,841,310
✉ Email this page to a colleague
Which drugs does patent 8,841,310 protect, and when does it expire?
Patent 8,841,310 protects COMPLERA and is included in one NDA.
This patent has two hundred and seventeen patent family members in forty-five countries.
Summary for Patent: 8,841,310
Title: | Combinations of a pyrimidine containing NNRTI with RT inhibitors |
Abstract: | The present invention concerns combinations of a pyrimidine containing NNRTI with nucleoside reverse transcriptase inhibitors and/or nucleotide reverse transcriptase inhibitors useful for the treatment of HIV infected patients or for the prevention of HIV transmission or infection. |
Inventor(s): | Stoffels; Paul (Hoogstraten, BE) |
Assignee: | Janssen R & D Ireland (Eastgate Village, Eastgate Little Island, Co. Cork, IE) |
Application Number: | 12/574,881 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,841,310 |
Patent Claim Types: see list of patent claims | Compound; Formulation; Composition; Dosage form; Use; Device; |
Drugs Protected by US Patent 8,841,310
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gilead Sciences Inc | COMPLERA | emtricitabine; rilpivirine hydrochloride; tenofovir disoproxil fumarate | TABLET;ORAL | 202123-001 | Aug 10, 2011 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | TREATMENT OF HIV INFECTION | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,841,310
International Family Members for US Patent 8,841,310
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
African Regional IP Organization (ARIPO) | 1610 | ⤷ Try a Trial | |||
African Regional IP Organization (ARIPO) | 2109 | ⤷ Try a Trial | |||
African Regional IP Organization (ARIPO) | 2296 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |